Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Ursodesoxycholic Acid in the Management of Non-Alcoholic Steatohepatitis

NCT00470171 is registered in ClinicalTrials.gov with Axcan Pharma as lead sponsor.

NCT NCT00470171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00470171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Ursodesoxycholic Acid in the Management of Non-Alcoholic Steatohepatitis
Lead sponsor
Axcan Pharma
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2005
Completion date
November 30, 2008
Enrollment
98 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

serum levels of alat transaminases, serum markers for fibrosis and hepatic inflammation